Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alterity Therapeutics ( (AU:ATH) ) has shared an announcement.
Alterity Therapeutics Limited announced the quotation of 79,999,800 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of July 17, 2025. This move is likely to enhance the company’s financial flexibility and market presence, potentially impacting its strategic operations and offering new opportunities for stakeholders.
More about Alterity Therapeutics
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapies for neurodegenerative diseases. The company is known for its innovative approaches in addressing conditions like Alzheimer’s and Parkinson’s disease.
YTD Price Performance: 20.0%
Average Trading Volume: 15,349,588
Technical Sentiment Signal: Sell
Current Market Cap: A$109.5M
See more insights into ATH stock on TipRanks’ Stock Analysis page.